Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 173 results for "mirati"

Mirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016
BioSpace

BRIEF-Broadfin Capital, LLC reports 5.02 pct passive stake in ...

Aug 10 Mirati Therapeutics Inc * Broadfin Capital, LLC reports 5.02 pct passive stake in Mirati Therapeutics as of August 8, 2016 - SEC Filing Source - bit.ly/2aMdcIv Further company coverage: Our top photos from the last 24 hours. ... Reuters UK, 1 month ago
Mirati Therapeutics reports Q2 EPS ($1.11), consensus ($1.15) Pettinga Financial Advisors, 1 month ago
[x]  

19 images for mirati

Before It's News, 1 month ago
Asian Hospital & Healthcare Management, 1 month ago
Yahoo! Singapore, 1 month ago
Before It's News, 1 month ago
ADVFN India, 3 months ago
FOXBusiness.com, 3 months ago
FOXBusiness.com, 3 months ago
Schaeffers Research, 3 months ago
Nasdaq, 3 months ago
Motley Fool, 3 months ago

SC 13G/A - Mirati Therapeutics, Inc. (0001576263) (Subject)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] SEC Accession No. 0000315066-16-006195 Filing Date 2016-09-12 2016-09-12 11:00:18 Filing Date Changed 2016-09-12 Document Format Files ...
 SEC Filings1 week ago SC 13G - Mirati Therapeutics, Inc. (0001576263) (Subject)  SEC Filings1 month ago SC 13G - Broadfin Capital, LLC (0001511901) (Filed by)  SEC Filings1 month ago

Piper Jaffray Cos. Reiterates Neutral Rating for Mirati Therapeutics Inc. (MRTX)

Mirati Therapeutics Inc. (NASDAQ:MRTX) s stock had its neutral rating reiterated by investment analysts at Piper Jaffray Cos. in a research report issued to clients and investors on Friday. Mirati Therapeutics ( NASDAQ:MRTX ) opened at 5.42 on ...
 Zolmax News1 month ago Piper Jaffray Cos. Analysts Give Mirati Therapeutics Inc. (MRTX) a $7.00 Price Target  Mideast Time1 month ago Mirati Therapeutics Inc. (MRTX) Stock Rating Reaffirmed by Piper Jaffray Cos.  SleekMoney1 month ago Mirati Therapeutics Inc. (MRTX) PT Set at $7.00 by Piper Jaffray Cos.  SleekMoney1 month ago
[x]  

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Gets 100 As The Impact Score

The Algorithm based analytics provided by Alpha One can help in determining the stock sentiment because they are based onvarious online channels on which content about a given company is published. Their tracking takes keen interest on the most ...
 Markets Daily3 days ago Mirati Therapeutics Inc. (NASDAQ:MRTX) Receives $24.44 Consensus Target Price from Analysts  WKRB News1 week ago 100 Is The Compact Score Of Mirati Therapeutics, Inc. (NASDAQ:MRTX)  Markets Daily2 weeks ago The Impact Score of Mirati Therapeutics, Inc. (NASDAQ:MRTX) Is 100  Markets Daily2 months ago
[x]  

Biggest Movers in Manufacturing Stocks Now AKS MDGL KIN MRTX

Popular Posts: Recent Posts: The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers. Some of the biggest gainers among Manufacturing stocks include: AK Steel Holding Corp ( AKS ): AKS ...
 InvestorPlace.com3 days ago Hottest Manufacturing Stocks Now VNDA PDEX DMPI YECO  InvestorPlace.com4 weeks ago

Global Molecular Diagnostics Strategic Business Report 2015-2022 - HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market

Dublin, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, ...
 BizWire Express2 days ago
[x]  

Riassunto: Visual IQ supporta la misurazione dellattribuzione cross-device grazie alla partnership con la piattaforma Atlas di Facebook

03:00 AMEastern Daylight Time I clienti di Visual IQ ora possono ottenere informazioni basate sulle persone per investimenti pi├╣ mirati LONDRA--( BUSINESS WIRE )-- Visual IQ , fornitore leader di software di attribuzione marketing ...
 BusinessWire.co.uk1 day ago

Positive Session Ends with Strong Finish

(AdviceTrade via COMTEX) -- by Harry Boxer, www.TheTechTrader an AdviceTrade.com publication The stock market indices had a very strong day today. They started the session with a gap to the upside, ran solidly to midday when they consolidated, ...
 TradingCharts.com2 days ago Positive Stock Market Session Ends with Strong Finish  Market Oracle1 day ago

CLVS, NKTR, RSYS, TERP

(AdviceTrade via COMTEX) -- by Harry Boxer, www.TheTechTrader an AdviceTrade.com publication The markets had a strong day on Thursday, with a gap up, run up, consolidation, they pulled back, held, and started back up near the end of the session.
 TradingCharts.com2 days ago

PharmaMar richiede all'EMA l'AIC per Aplidin®, il farmaco per il trattamento del mieloma multiplo

Sept. 22, 2016, 7 a.m. MADRID , September 22, 2016 /PRNewswire/ -- PharmaMar (MSE:PHM) ha reso noto oggi di aver inoltrato all'Agenzia Europea dei Medicinali ( EMA) la richiesta per l'autorizzazione all'immissione in commercio (AIC) di Aplidin ...
 Healthcare Dive2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less